Loading...
Comparison of the Efficacy of Innovator Rituximab and its Biosimilars in Diffuse Large B Cell Lymphoma Patients: A Retrospective Analysis
Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphoma among adults, although it also affects the young and the elderly. DLBCL is treated with a chimeric monoclonal antibody against CD20, a B cell surface protein, named rituximab, in combination with a multidrug chemot...
Saved in:
| Published in: | Indian J Hematol Blood Transfus |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer India
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7042466/ https://ncbi.nlm.nih.gov/pubmed/32174693 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-019-01167-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|